Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

CD16+NKG2Ahigh Natural Killer Cells Infiltrate Breast Cancer-Draining Lymph Nodes.

Frazao A, Messaoudene M, Nunez N, Dulphy N, Roussin F, Sedlik C, Zitvogel L, Piaggio E, Toubert A, Caignard A.

Cancer Immunol Res. 2018 Dec 4. doi: 10.1158/2326-6066.CIR-18-0085. [Epub ahead of print]

PMID:
30514793
2.

IL-17RA-Signaling Modulates CD8+ T Cell Survival and Exhaustion During Trypanosoma cruzi Infection.

Tosello Boari J, Araujo Furlan CL, Fiocca Vernengo F, Rodriguez C, Ramello MC, Amezcua Vesely MC, Gorosito Serrán M, Nuñez NG, Richer W, Piaggio E, Montes CL, Gruppi A, Acosta Rodríguez EV.

Front Immunol. 2018 Oct 11;9:2347. doi: 10.3389/fimmu.2018.02347. eCollection 2018.

3.

CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8+ T Cells-Response.

Canale FP, Ramello MC, Núñez N, Bossio SN, Piaggio E, Gruppi A, Rodríguez EVA, Montes CL.

Cancer Res. 2018 Sep 1;78(17):5175. doi: 10.1158/0008-5472.CAN-18-0950. Epub 2018 Aug 16. No abstract available.

PMID:
30115702
4.

Humanized Mice for the Study of Immuno-Oncology.

De La Rochere P, Guil-Luna S, Decaudin D, Azar G, Sidhu SS, Piaggio E.

Trends Immunol. 2018 Sep;39(9):748-763. doi: 10.1016/j.it.2018.07.001. Epub 2018 Aug 2. Review.

PMID:
30077656
5.

Induction of anergic or regulatory tumor-specific CD4+ T cells in the tumor-draining lymph node.

Alonso R, Flament H, Lemoine S, Sedlik C, Bottasso E, Péguillet I, Prémel V, Denizeau J, Salou M, Darbois A, Núñez NG, Salomon B, Gross D, Piaggio E, Lantz O.

Nat Commun. 2018 May 29;9(1):2113. doi: 10.1038/s41467-018-04524-x.

6.

Galectin-3 deficiency drives lupus-like disease by promoting spontaneous germinal centers formation via IFN-γ.

Beccaria CG, Amezcua Vesely MC, Fiocca Vernengo F, Gehrau RC, Ramello MC, Tosello Boari J, Gorosito Serrán M, Mucci J, Piaggio E, Campetella O, Acosta Rodríguez EV, Montes CL, Gruppi A.

Nat Commun. 2018 Apr 24;9(1):1628. doi: 10.1038/s41467-018-04063-5.

7.

Tumor Necrosis Factor α and Regulatory T Cells in Oncoimmunology.

Salomon BL, Leclerc M, Tosello J, Ronin E, Piaggio E, Cohen JL.

Front Immunol. 2018 Mar 12;9:444. doi: 10.3389/fimmu.2018.00444. eCollection 2018. Review.

8.

Systemic IL-2/anti-IL-2Ab complex combined with sublingual immunotherapy suppresses experimental food allergy in mice through induction of mucosal regulatory T cells.

Smaldini PL, Trejo F, Cohen JL, Piaggio E, Docena GH.

Allergy. 2018 Apr;73(4):885-895. doi: 10.1111/all.13402.

PMID:
29319881
9.

mRNA Expression levels of genes involved in antitumor immunity: Identification of a 3-gene signature associated with prognosis of muscle-invasive bladder cancer.

Le Goux C, Vacher S, Pignot G, Sibony M, Barry Delongchamps N, Terris B, Piaggio E, Zerbib M, Damotte D, Bieche I.

Oncoimmunology. 2017 Aug 14;6(11):e1358330. doi: 10.1080/2162402X.2017.1358330. eCollection 2017.

10.

CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8+ T Cells.

Canale FP, Ramello MC, Núñez N, Araujo Furlan CL, Bossio SN, Gorosito Serrán M, Tosello Boari J, Del Castillo A, Ledesma M, Sedlik C, Piaggio E, Gruppi A, Acosta Rodríguez EA, Montes CL.

Cancer Res. 2018 Jan 1;78(1):115-128. doi: 10.1158/0008-5472.CAN-16-2684. Epub 2017 Oct 24.

11.

Phenotype of NK-Like CD8(+) T Cells with Innate Features in Humans and Their Relevance in Cancer Diseases.

Barbarin A, Cayssials E, Jacomet F, Nunez NG, Basbous S, Lefèvre L, Abdallah M, Piccirilli N, Morin B, Lavoue V, Catros V, Piaggio E, Herbelin A, Gombert JM.

Front Immunol. 2017 Mar 27;8:316. doi: 10.3389/fimmu.2017.00316. eCollection 2017.

12.

Inhibition of effector antigen-specific T cells by intradermal administration of heme oxygenase-1 inducers.

Simon T, Pogu J, Rémy S, Brau F, Pogu S, Maquigneau M, Fonteneau JF, Poirier N, Vanhove B, Blancho G, Piaggio E, Anegon I, Blancou P.

J Autoimmun. 2017 Jul;81:44-55. doi: 10.1016/j.jaut.2017.03.005. Epub 2017 Mar 23.

PMID:
28342735
13.

Mechanisms of Resistance to Immune Checkpoint Antibodies.

Ramos RN, Piaggio E, Romano E.

Handb Exp Pharmacol. 2018;249:109-128. doi: 10.1007/164_2017_11.

PMID:
28315073
14.

Loss of immune tolerance to IL-2 in type 1 diabetes.

Pérol L, Lindner JM, Caudana P, Nunez NG, Baeyens A, Valle A, Sedlik C, Loirat D, Boyer O, Créange A, Cohen JL, Rogner UC, Yamanouchi J, Marchant M, Leber XC, Scharenberg M, Gagnerault MC, Mallone R, Battaglia M, Santamaria P, Hartemann A, Traggiai E, Piaggio E.

Nat Commun. 2016 Oct 6;7:13027. doi: 10.1038/ncomms13027.

15.

Effective antitumor therapy based on a novel antibody-drug conjugate targeting the Tn carbohydrate antigen.

Sedlik C, Heitzmann A, Viel S, Ait Sarkouh R, Batisse C, Schmidt F, De La Rochere P, Amzallag N, Osinaga E, Oppezzo P, Pritsch O, Sastre-Garau X, Hubert P, Amigorena S, Piaggio E.

Oncoimmunology. 2016 Apr 22;5(7):e1171434. doi: 10.1080/2162402X.2016.1171434. eCollection 2016 Jul.

16.

Heparan sulfates targeting increases MHC class I- and MHC class II-restricted antigen presentation and CD8(+) T-cell response.

Knittel D, Gadzinski A, Hua S, Denizeau J, Savatier A, de la Rochère P, Boulain JC, Amigorena S, Piaggio E, Sedlik C, Léonetti M.

Vaccine. 2016 Jun 8;34(27):3093-3101. doi: 10.1016/j.vaccine.2016.04.073. Epub 2016 May 4.

PMID:
27154391
17.

Inhibition of the JAK/STAT Signaling Pathway in Regulatory T Cells Reveals a Very Dynamic Regulation of Foxp3 Expression.

Goldstein JD, Burlion A, Zaragoza B, Sendeyo K, Polansky JK, Huehn J, Piaggio E, Salomon BL, Marodon G.

PLoS One. 2016 Apr 14;11(4):e0153682. doi: 10.1371/journal.pone.0153682. eCollection 2016. Erratum in: PLoS One. 2016;11(6):e0157629.

18.

Regulatory T cells delay disease progression in Alzheimer-like pathology.

Dansokho C, Ait Ahmed D, Aid S, Toly-Ndour C, Chaigneau T, Calle V, Cagnard N, Holzenberger M, Piaggio E, Aucouturier P, Dorothée G.

Brain. 2016 Apr;139(Pt 4):1237-51. doi: 10.1093/brain/awv408. Epub 2016 Feb 1.

PMID:
26912648
19.

New Molecular and Cellular Mechanisms of Tolerance: Tolerogenic Actions of IL-2.

Pérol L, Piaggio E.

Methods Mol Biol. 2016;1371:11-28. doi: 10.1007/978-1-4939-3139-2_2. Review.

PMID:
26530792
20.

C-terminal cleavage of human Foxp3 at a proprotein convertase motif abrogates its suppressive function.

Elhage R, Cheraï M, Levacher B, Darrasse-Jeze G, Baillou C, Zhao X, Khatib AM, Piaggio E, Klatzmann D.

Scand J Immunol. 2015 Apr;81(4):229-39. doi: 10.1111/sji.12275.

21.

Heterogeneous CD3 expression levels in differing T cell subsets correlate with the in vivo anti-CD3-mediated T cell modulation.

Valle A, Barbagiovanni G, Jofra T, Stabilini A, Perol L, Baeyens A, Anand S, Cagnard N, Gagliani N, Piaggio E, Battaglia M.

J Immunol. 2015 Mar 1;194(5):2117-27. doi: 10.4049/jimmunol.1401551. Epub 2015 Feb 2.

22.

Effector T cells boost regulatory T cell expansion by IL-2, TNF, OX40, and plasmacytoid dendritic cells depending on the immune context.

Baeyens A, Saadoun D, Billiard F, Rouers A, Grégoire S, Zaragoza B, Grinberg-Bleyer Y, Marodon G, Piaggio E, Salomon BL.

J Immunol. 2015 Feb 1;194(3):999-1010. doi: 10.4049/jimmunol.1400504. Epub 2014 Dec 29.

23.

Immunoendocrine dysbalance during uncontrolled T. cruzi infection is associated with the acquisition of a Th-1-like phenotype by Foxp3(+) T cells.

González FB, Villar SR, Fernández Bussy R, Martin GH, Pérol L, Manarin R, Spinelli SV, Pilon C, Cohen JL, Bottasso OA, Piaggio E, Pérez AR.

Brain Behav Immun. 2015 Mar;45:219-32. doi: 10.1016/j.bbi.2014.11.016. Epub 2014 Dec 5.

PMID:
25483139
24.

Potential limitations of IL-2 administration for the treatment of experimental acute graft-versus-host disease.

Pérol L, Martin GH, Maury S, Cohen JL, Piaggio E.

Immunol Lett. 2014 Dec;162(2 Pt B):173-84. doi: 10.1016/j.imlet.2014.10.027. Epub 2014 Nov 5.

PMID:
25445496
25.

Administration of low doses of IL-2 combined to rapamycin promotes allogeneic skin graft survival in mice.

Pilon CB, Petillon S, Naserian S, Martin GH, Badoual C, Lang P, Azoulay D, Piaggio E, Grimbert P, Cohen JL.

Am J Transplant. 2014 Dec;14(12):2874-82. doi: 10.1111/ajt.12944. Epub 2014 Nov 13.

26.

Sustained stimulation and expansion of Tregs by IL2 control autoimmunity without impairing immune responses to infection, vaccination and cancer.

Churlaud G, Jimenez V, Ruberte J, Amadoudji Zin M, Fourcade G, Gottrand G, Casana E, Lambrecht B, Bellier B, Piaggio E, Bosch F, Klatzmann D.

Clin Immunol. 2014 Apr;151(2):114-26. doi: 10.1016/j.clim.2014.02.003. Epub 2014 Feb 19.

PMID:
24576619
27.

Role of cytokines in thymus- versus peripherally derived-regulatory T cell differentiation and function.

Goldstein JD, Pérol L, Zaragoza B, Baeyens A, Marodon G, Piaggio E.

Front Immunol. 2013 Jun 19;4:155. doi: 10.3389/fimmu.2013.00155. eCollection 2013.

28.

Limitations of IL-2 and rapamycin in immunotherapy of type 1 diabetes.

Baeyens A, Pérol L, Fourcade G, Cagnard N, Carpentier W, Woytschak J, Boyman O, Hartemann A, Piaggio E.

Diabetes. 2013 Sep;62(9):3120-31. doi: 10.2337/db13-0214. Epub 2013 May 13.

29.

Carbon monoxide-treated dendritic cells decrease β1-integrin induction on CD8⁺ T cells and protect from type 1 diabetes.

Simon T, Pogu S, Tardif V, Rigaud K, Rémy S, Piaggio E, Bach JM, Anegon I, Blancou P.

Eur J Immunol. 2013 Jan;43(1):209-18. doi: 10.1002/eji.201242684. Epub 2012 Dec 11.

30.

A specific subpopulation of mesenchymal stromal cell carriers overrides melanoma resistance to an oncolytic adenovirus.

Bolontrade MF, Sganga L, Piaggio E, Viale DL, Sorrentino MA, Robinson A, Sevlever G, García MG, Mazzolini G, Podhajcer OL.

Stem Cells Dev. 2012 Sep 20;21(14):2689-702. doi: 10.1089/scd.2011.0643. Epub 2012 May 14.

31.

[Could we cure type 1 diabetes by stimulating T(reg)?].

Grinberg-Bleyer Y, Baeyens A, Piaggio E, Salomon BL.

Med Sci (Paris). 2011 May;27(5):471-2. doi: 10.1051/medsci/2011275008. Epub 2011 May 25. French. No abstract available.

32.

Immune reconstitution is preserved in hematopoietic stem cell transplantation coadministered with regulatory T cells for GVHD prevention.

Gaidot A, Landau DA, Martin GH, Bonduelle O, Grinberg-Bleyer Y, Matheoud D, Grégoire S, Baillou C, Combadière B, Piaggio E, Cohen JL.

Blood. 2011 Mar 10;117(10):2975-83. doi: 10.1182/blood-2010-08-299974. Epub 2010 Dec 30.

33.

Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs.

Grinberg-Bleyer Y, Saadoun D, Baeyens A, Billiard F, Goldstein JD, Grégoire S, Martin GH, Elhage R, Derian N, Carpentier W, Marodon G, Klatzmann D, Piaggio E, Salomon BL.

J Clin Invest. 2010 Dec;120(12):4558-68. doi: 10.1172/JCI42945. Epub 2010 Nov 22.

34.

IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells.

Grinberg-Bleyer Y, Baeyens A, You S, Elhage R, Fourcade G, Gregoire S, Cagnard N, Carpentier W, Tang Q, Bluestone J, Chatenoud L, Klatzmann D, Salomon BL, Piaggio E.

J Exp Med. 2010 Aug 30;207(9):1871-8. doi: 10.1084/jem.20100209. Epub 2010 Aug 2.

35.

Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction.

Tang Q, Adams JY, Penaranda C, Melli K, Piaggio E, Sgouroudis E, Piccirillo CA, Salomon BL, Bluestone JA.

Immunity. 2008 May;28(5):687-97. doi: 10.1016/j.immuni.2008.03.016. Epub 2008 May 8.

36.

Multimerized T cell epitopes protect from experimental autoimmune diabetes by inducing dominant tolerance.

Piaggio E, Mars LT, Cassan C, Cabarrocas J, Hofstätter M, Desbois S, Bergereau E, Rötzschke O, Falk K, Liblau RS.

Proc Natl Acad Sci U S A. 2007 May 29;104(22):9393-8. Epub 2007 May 16.

37.

Pertussis toxin reduces the number of splenic Foxp3+ regulatory T cells.

Cassan C, Piaggio E, Zappulla JP, Mars LT, Couturier N, Bucciarelli F, Desbois S, Bauer J, Gonzalez-Dunia D, Liblau RS.

J Immunol. 2006 Aug 1;177(3):1552-60.

38.

Foxp3+ CD25+ regulatory T cells specific for a neo-self-antigen develop at the double-positive thymic stage.

Cabarrocas J, Cassan C, Magnusson F, Piaggio E, Mars L, Derbinski J, Kyewski B, Gross DA, Salomon BL, Khazaie K, Saoudi A, Liblau RS.

Proc Natl Acad Sci U S A. 2006 May 30;103(22):8453-8. Epub 2006 May 18.

39.

T-cell homing to the pancreas in autoimmune mouse models of diabetes: in vivo MR imaging.

Billotey C, Aspord C, Beuf O, Piaggio E, Gazeau F, Janier MF, Thivolet C.

Radiology. 2005 Aug;236(2):579-87. Epub 2005 Jun 21.

PMID:
15972338
40.

Blood viscosity changes in experimentally Trypanosoma cruzi-infected rats.

Berra HH, Piaggio E, Revelli SS, Luquita A.

Clin Hemorheol Microcirc. 2005;32(3):175-82.

PMID:
15851836
41.

Hepatitis B vaccination and central nervous system demyelination: an immunological approach.

Piaggio E, Ben Younes A, Desbois S, Gout O, Tourbah A, Lyon-Caen O, Liblau RS.

J Autoimmun. 2005 Feb;24(1):33-7. Epub 2005 Jan 18.

PMID:
15725574
42.

A transgenic mouse model for T-cell ignorance of a glial autoantigen.

Cabarrocas J, Piaggio E, Zappulla JP, Desbois S, Mars LT, Lassmann H, Liblau RS.

J Autoimmun. 2004 May;22(3):179-89.

PMID:
15041038
43.

Maintaining or breaking CD8+ T-cell tolerance to beta islet cell antigens: lessons from transgenic mouse models.

Piaggio E, Hartemann-Heurtier A, Cabarrocas J, Desbois S, Mars LT, Zappulla JP, Liblau RS.

J Autoimmun. 2004 Mar;22(2):115-20. Review. No abstract available.

PMID:
14987739
44.

An altered self-peptide with superagonist activity blocks a CD8-mediated mouse model of type 1 diabetes.

Hartemann-Heurtier A, Mars LT, Bercovici N, Desbois S, Cambouris C, Piaggio E, Zappulla J, Saoudi A, Liblau RS.

J Immunol. 2004 Jan 15;172(2):915-22.

45.

Effective and selective immune surveillance of the brain by MHC class I-restricted cytotoxic T lymphocytes.

Cabarrocas J, Bauer J, Piaggio E, Liblau R, Lassmann H.

Eur J Immunol. 2003 May;33(5):1174-82.

46.

Effect of dithiocarbamate pesticide zineb and its commercial formulation, azzurro. III. Genotoxic evaluation on Chinese hamster ovary (CHO) cells.

Soloneski S, González M, Piaggio E, Reigosa MA, Larramendy ML.

Mutat Res. 2002 Feb 15;514(1-2):201-12.

PMID:
11815258
47.

Effect of the dithiocarbamate pesticide zineb and its commercial formulation azzurro. I. Genotoxic evaluation on cultured human lymphocytes exposed in vitro.

Soloneski S, González M, Piaggio E, Apezteguía M, Reigosa MA, Larramendy ML.

Mutagenesis. 2001 Nov;16(6):487-93.

PMID:
11682639
48.
49.

Treatment with benznidazole and its immunomodulating effects on Trypanosoma cruzi-infected rats.

Piaggio E, Roggero E, Pitashny M, Wietzerbin J, Bottasso OA, Revelli SS.

Parasitol Res. 2001 Jul;87(7):539-47.

PMID:
11484850
50.

Effects of halothane reexposure in female mice and their offspring.

Puig NR, Amerio N, Piaggio E, Barragán J, Comba JO, Elena GA.

Reprod Toxicol. 1999 Sep-Oct;13(5):361-7.

PMID:
10560584

Supplemental Content

Loading ...
Support Center